Literature DB >> 27844310

Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis.

Paolo Perrini1, Carlo Gambacciani2, Alessandro Weiss2, Francesco Pasqualetti3, Durim Delishaj3, Fabiola Paiar3, Riccardo Morganti4, Riccardo Vannozzi2, Lodovico Lutzemberger2.   

Abstract

The aim of the present study is to evaluate the impact of extent of resection at initial and repeat craniotomy on overall survival of patients with recurrent glioblastoma. The authors retrospectively reviewed the records of all adults patients who underwent repeat resection of recurrent glioblastoma following radiation and chemotherapy at an academic tertiary-care institution between 2011 and 2015. We evaluated the survival outcomes with regard to extent of resection considering both the initial and repeat resections. The role of possible prognostic factors that may affect survival after repeat resection, including age, preoperative performance status, tumor location and adjuvant treatment, was evaluated using Cox regression analyses. Forty-eight patients were included in this study. The overall median survival of 14 patients who had subtotal resection at recurrence after initial subtotal resection did not statistically differ from seven patients who had gross-total resection at recurrence after initial subtotal resection (18 months vs. 22 months, p = 0.583). The overall median survival of 13 patients who had gross-total resection at recurrence after initial gross-total resection was significantly increased compared with survival of 13 patients who had subtotal resection at recurrence after initial gross-total resection (47 months vs. 14 months, p = 0.009). A Cox proportional hazards model was created demonstrating that preoperative performance status at recurrence (HR 0.418, p = 0.035) and the extent of repeat resection (HR 0.513, p = 0.043) were independent predictors of survival. Gross-total resection at repeat craniotomy is associated with longer overall survival and should be performed whenever possible in patients with recurrent glioblastoma and in good performance status.

Entities:  

Keywords:  Extent of resection; Glioblastoma; Recurrent glioma; Surgery; Survival

Mesh:

Year:  2016        PMID: 27844310     DOI: 10.1007/s11060-016-2330-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  21 in total

Review 1.  Brain tumors.

Authors:  L M DeAngelis
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

2.  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

Authors:  Patrick Y Wen; David R Macdonald; David A Reardon; Timothy F Cloughesy; A Gregory Sorensen; Evanthia Galanis; John Degroot; Wolfgang Wick; Mark R Gilbert; Andrew B Lassman; Christina Tsien; Tom Mikkelsen; Eric T Wong; Marc C Chamberlain; Roger Stupp; Kathleen R Lamborn; Michael A Vogelbaum; Martin J van den Bent; Susan M Chang
Journal:  J Clin Oncol       Date:  2010-03-15       Impact factor: 44.544

3.  Scale to predict survival after surgery for recurrent glioblastoma multiforme.

Authors:  John K Park; Tiffany Hodges; Leopold Arko; Michael Shen; Donna Dello Iacono; Adrian McNabb; Nancy Olsen Bailey; Teri Nguyen Kreisl; Fabio M Iwamoto; Joohee Sul; Sungyoung Auh; Grace E Park; Howard A Fine; Peter McL Black
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

Review 4.  Second surgery for recurrent glioblastoma: A concise overview of the current literature.

Authors:  Nicola Montemurro; Paolo Perrini; Magdalena Olivares Blanco; Riccardo Vannozzi
Journal:  Clin Neurol Neurosurg       Date:  2016-01-14       Impact factor: 1.876

5.  Survival and functional status after resection of recurrent glioblastoma multiforme.

Authors:  F G Barker; S M Chang; P H Gutin; M K Malec; M W McDermott; M D Prados; C B Wilson
Journal:  Neurosurgery       Date:  1998-04       Impact factor: 4.654

6.  An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.

Authors:  Mark E Oppenlander; Andrew B Wolf; Laura A Snyder; Robert Bina; Jeffrey R Wilson; Stephen W Coons; Lynn S Ashby; David Brachman; Peter Nakaji; Randall W Porter; Kris A Smith; Robert F Spetzler; Nader Sanai
Journal:  J Neurosurg       Date:  2014-01-31       Impact factor: 5.115

7.  Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.

Authors:  Orin Bloch; Seunggu J Han; Soonmee Cha; Matthew Z Sun; Manish K Aghi; Michael W McDermott; Mitchel S Berger; Andrew T Parsa
Journal:  J Neurosurg       Date:  2012-10-05       Impact factor: 5.115

Review 8.  Reoperation for recurrent high-grade glioma: a current perspective of the literature.

Authors:  Shawn L Hervey-Jumper; Mitchel S Berger
Journal:  Neurosurgery       Date:  2014-11       Impact factor: 4.654

9.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Authors:  Matthew J McGirt; Kaisorn L Chaichana; Muraya Gathinji; Frank J Attenello; Khoi Than; Alessandro Olivi; Jon D Weingart; Henry Brem; Alf Redo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

10.  Histopathological correlates with survival in reoperated glioblastomas.

Authors:  Graeme F Woodworth; Tomas Garzon-Muvdi; Xiaobu Ye; Jaishri O Blakeley; Jon D Weingart; Peter C Burger
Journal:  J Neurooncol       Date:  2013-05-11       Impact factor: 4.130

View more
  11 in total

1.  A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma.

Authors:  Christina Jackson; John Choi; Adham M Khalafallah; Carrie Price; Chetan Bettegowda; Michael Lim; Gary Gallia; Jon Weingart; Henry Brem; Debraj Mukherjee
Journal:  J Neurooncol       Date:  2020-06-19       Impact factor: 4.130

2.  Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma.

Authors:  Francesco Pasqualetti; Nicola Montemurro; Isacco Desideri; Mauro Loi; Noemi Giannini; Giovanni Gadducci; Giulia Malfatti; Martina Cantarella; Alessandra Gonnelli; Sabrina Montrone; Luca Visani; Cristian Scatena; Antonio Giuseppe Naccarato; Paolo Perrini; Carlo Gambacciani; Orazio Santonocito; Riccardo Morganti; Fabiola Paiar
Journal:  Acta Neurol Belg       Date:  2021-08-16       Impact factor: 2.396

3.  Role of magnetic resonance imaging following postoperative radiotherapy in clinical decision-making of patients with high-grade glioma.

Authors:  Francesco Pasqualetti; Giulia Malfatti; Martina Cantarella; Alessandra Gonnelli; Sabrina Montrone; Nicola Montemurro; Giovanni Gadducci; Noemi Giannini; Ilaria Pesaresi; Paolo Perrini; Riccardo Morganti; Mirco Cosottini; Fabiola Paiar
Journal:  Radiol Med       Date:  2022-05-24       Impact factor: 6.313

4.  Glioblastoma Treated With Magnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy: Safety, Efficacy, and Outcomes.

Authors:  Ashwin A Kamath; Daniel D Friedman; S Hassan A Akbari; Albert H Kim; Yu Tao; Jinqin Luo; Eric C Leuthardt
Journal:  Neurosurgery       Date:  2019-04-01       Impact factor: 4.654

5.  Clinical Outcome of Cytoreductive Surgery Prior to Bevacizumab for Patients with Recurrent Glioblastoma: A Single-center Retrospective Analysis.

Authors:  Shigeru Yamaguchi; Hiroaki Motegi; Yukitomo Ishi; Michinari Okamoto; Ryosuke Sawaya; Hiroyuki Kobayashi; Shunsuke Terasaka; Kiyohiro Houkin
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-03-04       Impact factor: 1.742

6.  Primary versus recurrent surgery for glioblastoma-a prospective cohort study.

Authors:  Maja Chava Rubin; Lisa Millgård Sagberg; Asgeir Store Jakola; Ole Solheim
Journal:  Acta Neurochir (Wien)       Date:  2020-10-14       Impact factor: 2.216

7.  Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.

Authors:  Francesco Pasqualetti; Celeste Giampietro; Nicola Montemurro; Noemi Giannini; Giovanni Gadducci; Paola Orlandi; Eleonora Natali; Paolo Chiarugi; Alessandra Gonnelli; Martina Cantarella; Cristian Scatena; Giuseppe Nicolò Fanelli; Antonio Giuseppe Naccarato; Paolo Perrini; Gaetano Liberti; Riccardo Morganti; Maria Franzini; Aldo Paolicchi; Giovanni Pellegrini; Guido Bocci; Fabiola Paiar
Journal:  Genes (Basel)       Date:  2022-06-13       Impact factor: 4.141

8.  Second surgery for progressive glioblastoma: a multi-centre questionnaire and cohort-based review of clinical decision-making and patient outcomes in current practice.

Authors:  P M Brennan; R Borchert; C Coulter; G R Critchley; B Hall; D Holliman; I Phang; S J Jefferies; S Keni; L Lee; I Liaquat; H J Marcus; S Thomson; L Thorne; M Vintu; A N Wiggins; M D Jenkinson; S Erridge
Journal:  J Neurooncol       Date:  2021-03-31       Impact factor: 4.130

9.  Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature.

Authors:  Nicola Montemurro; Paolo Perrini; Biagio Rapone
Journal:  Int J Environ Res Public Health       Date:  2020-11-17       Impact factor: 3.390

10.  Age-adjusted Charlson comorbidity index in recurrent glioblastoma: a new prognostic factor?

Authors:  Melanie Barz; Stefanie Bette; Insa Janssen; A Kaywan Aftahy; Thomas Huber; Friederike Liesche-Starnecker; Yu-Mi Ryang; Benedikt Wiestler; Stephanie E Combs; Bernhard Meyer; Jens Gempt
Journal:  BMC Neurol       Date:  2022-01-21       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.